Zostavax
Vaccination safety alert
Warning issued after the death of an immuno-compromised patient following Zostavax administration The Therapeutic Goods Administration has reiterated previous warnings about administering the Zostavax shingles vaccine to patients with immune …
Health professionals reminded of Zostavax safety risk
The TGA has received a report of a death occurring in a person with pre-existing compromised immune function after receiving Zostavax The vaccine for the prevention of herpes zoster has …
Zostavax shortage due to unexpected popularity
Reports have emerged two weeks after the shingles vaccine was added to the National Immunisation Program Zostavax is Australia’s only vaccine to protect against shingles and postherpetic neuralgia, and on 1 …
Zoster vaccine added to NIP
Those aged 70-79 can now freely access the vaccine, which aims to protect against shingles and related neuropathic pain From 1 November, Australia’s only vaccine to protect against shingles and …